Xerostomia Therapeutics Market Analysis By Type(Artificial Saliva/Saliva Substitutes, Salivary Stimulants), By Product(Drugs, Salivary Pens), By Distribution Channel(Retail Pharmacies, Hospital Pharmacies, Online Pharmacies) & Forecast 2023-2032
The global xerostomia therapeutics market size was valued at USD 650 million in 2021 and is projected to reach around USD 950 million in 2030 exhibiting a CAGR of 3.5% in the forecasted period. The rising adoption of chemotherapy and radiotherapy in cancer treatment coupled with increasing use of prescribed medications are some of the key factors projected to drive the market. Increase in the patients with diabetes around the globe impact the salivary glands. Also, consuming medicines can have a range of side effects where one of them is dry mouth. Therefore, people liable more and more and medicines are in a way backing to the growth of the xerostomia therapeutics market. Growing creativity and consciousness of the same is also endorsing the growth of the market. On the other hand, finger-prick autologous blood treatment, along with low level of awareness about the same in undersized nations can be a restraint in the growth of this market. https://wemarketresearch.com/r....eports/xerostomia-th
